Business Wire

Donut King to Launch in Scandinavia

24.7.2017 09:00 | Business Wire

Jaa

Global food and beverage company, Retail Food Group Limited (RFG, the Company or Group), is making waves in international markets, having announced its entry into the Scandinavian market via the grant of Swedish Master Franchise rights for Australia’s largest speciality donut retailer, Donut King.

BC Food & Beverage AB, representing a firm of experienced Swedish businessmen, has secured the Master Franchise rights and plans on establishing its first Donut King outlet in the Uppsala region before Christmas 2017. The firm is extremely confident that Donut King’s warm cinnamon donuts and espresso coffees will be well received within the Swedish market, with many sub-franchise enquiries having already been received.

RFG Chief Executive – International, Mike Gilbert, noted that Scandinavia had been identified as a key growth market for the Donut King Brand System, and the Company was pleased to be joining forces with a strong and experienced Master Franchise Partner.

“During the past three decades, Donut King has evolved into Australia’s largest specialty donut and coffee destination, treating over 20 million customers per year to its world-famous cinnamon donuts and wide range of speciality treats. Donut King has also built a loyal customer following amongst a number of international markets, and we feel the time is now right to introduce the brand within Scandinavia,” he said.

Mike said interest in sub-franchising within the region is already proving strong, with the team fielding enquiries for new outlets, ahead of the first store even opening.

“RFG has been conscious to partner with robust Master Franchisees capable of applying sufficient resources, expertise and resolve to ensuring the successful entry of Donut King into new territories. BC Food & Beverage AB satisfies each of these pre-requisites and we have every confidence of the Brand’s success in Sweden under its stewardship.”

RFG is Australia’s largest multi-brand retail food franchise owner, developer and manager, with a network of more than 2,500 outlets across 12 Brand Systems, including Donut King, spanning 80 licensed international territories.

Mr Gilbert noted that growing international penetration of RFG’s Brand Systems within new territories, principally by partnering with robust Master Franchisees who share the Company’s vision, remains a focus for the Group.

“This model provides the Company and local partners with the opportunity to forge sustainable partnerships to successfully develop RFG’s Brand Systems internationally, whilst drawing on the Group’s more than 30 years’ experience in retail food franchising.”

“Our franchise partners enjoy the benefits of working with Australia’s largest multi-food franchisor every day, dealing with our expert management teams, enjoying supply benefits from increased scale and gaining access to best-in-class initiatives,” Mr Gilbert said.

About Retail Food Group Limited :

RFG owns the Donut King, Brumby’s Bakery, Michel’s Patisserie, bb’s Café, Esquires, Gloria Jean’s Coffees, It’s A Grind, The Coffee Guy, Café2U, Pizza Capers Gourmet Kitchen and Crust Gourmet Pizza Bar franchise systems. As well, Retail Food Group is a global coffee specialist with an integrated approach to sourcing, roasting and distributing high-quality coffee. Combining passion with expertise, the Company creates an unforgettable experience, from crop to cup, through its suite of coffee brands. RFG is looking to partner with Master Franchise candidates who share its vision for delivering exceptional products and service within international markets. Enquiries should be directed to Olivia Palmer at rfginternational@rfg.com.au.

Contact information

Retail Food Group
Annie Lyon, 0431 306 727
Corporate Communications Manager
annie.lyon@rfg.com.au

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 16:25Tiedote

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 15:00Tiedote

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 11:03Tiedote

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 11:00Tiedote

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 10:08Tiedote

Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven

Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 09:00Tiedote

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme